Evidence map›Paper›PMID 23501591›Full record

ArticleExperimental eye research2013

Specific sphingolipid content decrease in Cerkl knockdown mouse retinas.

Alejandro Garanto, Nawajes A Mandal, Meritxell Egido-Gabás, Gemma Marfany, Gemma Fabriàs, Robert E Anderson, Josefina Casas, Roser Gonzàlez-Duarte

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Experimental biology and medicine (Maywood, N.J.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Primary versus Secondary Elevations in Fundus Autofluorescence.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. International journal of molecular sciences · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Partial characterization of the lipidome of the cold-water scallop, Chlamys islandica.Environmental science and pollution research international · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Alejandro GarantoDepartament de Genètica, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
Nawajes A Mandal
Meritxell Egido-Gabás
Gemma Marfany
Gemma Fabriàs
Robert E Anderson
Josefina Casas
Roser Gonzàlez-Duarte
Instituto de Química Orgánica General · ESDean McGee Eye Institute · USCentre for Biomedical Network Research on Rare Diseases · ESInstituto de Salud Carlos III · ESUniversitat de Barcelona · ES

Funding

UNDERSTANDING THE ROLE OF RETINOL DEHYDROGENASES RDH11 AND RDH12 IN VISIONP20RR017703 · NCRR · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CERESA, BRIAN P. · 2002 to 2011
$23.6M
P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
ROLE OF LIPID PEROXIDATIONS IN RETINAL DEGENERATIONSR01EY004149 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ANDERSON, ROBERT E · 1985 to 2018
$8.3M
SECOND MESSENGERS IN THE RETINAR01EY000871 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RAJALA, RAJU VS · 1985 to 2020
$7.2M
CORE--MOLECULAR BIOLOGYP30EY012190 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ANDERSON, ROBERT E · 1999 to 2009
$5.2M
Sphingolipid Metabolism and Signaling in the RetinaR01EY022071 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI MANDAL, NAWAJES · 2012 to 2016
$1.8M
BLRD VA I01 BX004893NCRR NIH HHS P20 RR017703NCRR NIH HHS RR17703NEI NIH HHS EY00871NEI NIH HHS EY 022071NEI NIH HHS EY04149NEI NIH HHS EY12190NEI NIH HHS EY21725NEI NIH HHS P30 EY012190NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY000871NEI NIH HHS R01 EY004149NEI NIH HHS R01 EY022071
6 · The paper itself

Abstract

Sphingolipids (SPLs) are finely tuned structural compounds and bioactive molecules involved in membrane fluidity and cellular homeostasis. The core sphingolipid, ceramide (CER), and its derivatives, regulate several crucial processes in neuronal cells, among them cell differentiation, cell-cell interactions, membrane conductance, synaptic transmission, and apoptosis. Mutations in Ceramide Kinase-Like (CERKL) cause autosomal recessive Retinitis Pigmentosa and Cone Rod Dystrophy. The presence of a conserved lipid kinase domain and the overall similarity with CERK suggested that CERKL might play a role in the SPL metabolism as a CER kinase. Unfortunately, CERKL function and substrate(s), as well as its contribution to the retinal etiopathology, remain as yet unknown. In this work we aimed to characterize the mouse retinal sphingolipidome by UPLC-TOF to first, thoroughly investigate the SPL composition of the murine retina, compare it to our Cerkl -/- model, and finally assess new possible CERKL substrates by phosphorus quantification and protein-lipid overlay. Our results showed a consistent and notable decrease of the retinal SPL content (mainly ranging from 30% to 60%) in the Cerkl -/- compared to WT retinas, which was particularly evident in the glucosyl/galactosyl ceramide species (Glc/GalCer) whereas the phospholipids and neutral lipids remained unaltered. Moreover, evidence in favor of CERKL binding to GlcCer, GalCer and sphingomyelin has been gathered. Altogether, these results highlight the involvement of CERKL in the SPL metabolism, question its role as a kinase, and open new scenarios concerning its function.

Indexed as

AnimalsCeramidesChromatography, High Pressure LiquidGlycosphingolipidsHEK293 CellsHumansLipid MetabolismMiceMice, Inbred C57BLMice, KnockoutPhospholipidsPhosphotransferases (Alcohol Group Acceptor)Real-Time Polymerase Chain ReactionRetinaRetinitis PigmentosaRNACeramidesCerkL protein, mousedihydroceramideGlycosphingolipidsPhospholipidsPhosphotransferases (Alcohol Group Acceptor)RNASphingolipidsSphingomyelinsSphingosine

Identifiers

PMID23501591
PMCPMC4019014
OpenAlexW2075248572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.